?konomi PLEGRIDY? (PEGINTERFERON BETA-1A) TWO-YEAR DATA CONFIRM MAINTENANCE OF EFFICACY AND SAFETY IN MULTIPLE SCLEROSIS PATIENTS 30 september 201415 desember 2019y6.no
Vitenskap PLEGRIDY? (PEGINTERFERON BETA-1A) APPROVED IN THE EUROPEAN UNION FOR THE TREATMENT OF MULTIPLE SCLEROSIS 11 august 201415 desember 2019y6.no
Vitenskap CHMP ADOPTS POSITIVE OPINION FOR PLEGRIDYTM (PEGINTERFERON BETA-1A) AS A TREATMENT FOR MULTIPLE SCLEROSIS IN THE EUROPEAN UNION 28 mai 201415 desember 2019y6.no
Milj? BIOGEN IDEC ANNOUNCES POSITIVE TOP-LINE RESULTS FROM PHASE 3 STUDY OF PEGINTERFERON BETA-1A IN MULTIPLE SCLEROSIS 25 januar 201315 desember 2019y6.no
